Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Pacific Biosciences
(NASDAQ:PACB)
Intraday
$1.37
-0.03
[-2.14%]
After-Hours
$1.37
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$1.37
-0.03
[-2.14%]
At close: Apr 18
$1.37
0
[0.00%]
PreMarket: 6:35AM EDT
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Pacific Biosciences Stock (NASDAQ:PACB)
Pacific Biosciences Stock (NASDAQ: PACB)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, April 17, 2024
A Glimpse Into The Expert Outlook On Pacific Biosciences Through 4 Analysts
Benzinga Insights
-
14 hours ago
TD Cowen Maintains Buy on Pacific Biosciences, Lowers Price Target to $2.5
Benzinga Newsdesk
-
19 hours ago
Why INVO Bioscience Shares Are Trading Higher By Around 73%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
-
1 day ago
Tuesday, April 16, 2024
S&P 500 Edges Lower; PacBio Shares Plunge
Avi Kapoor
-
1 day ago
Why Skillsoft Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Avi Kapoor
-
1 day ago
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga Insights
-
1 day ago
Gold Moves Higher; Morgan Stanley Earnings Top Views
Avi Kapoor
-
1 day ago
Dow Gains Over 100 Points; Bank of America Posts Upbeat Profit
Avi Kapoor
-
1 day ago
PacBio shares are trading lower after the company issued weak guidance.
Benzinga Newsdesk
-
1 day ago
PacBio Sees Prelim. Q1 Revenue $38.8M vs $50.27M Est.; Sees 2024 Revenue $170M-$200M vs $238.67M Est.
Benzinga Newsdesk
-
1 day ago
Wednesday, April 10, 2024
Barclays Maintains Equal-Weight on Pacific Biosciences, Lowers Price Target to $3
Benzinga Newsdesk
-
Apr 10, 2024, 3:29PM
Goldman Sachs Maintains Buy on Pacific Biosciences, Lowers Price Target to $7
Benzinga Newsdesk
-
Apr 10, 2024, 9:32AM
Wednesday, March 27, 2024
Estonia National Biobank Selects PacBio To Sequence 10,000 Whole Genomes
Happy Mohamed
-
Mar 27, 2024, 8:10AM
Friday, March 22, 2024
Canaccord Genuity Maintains Buy on Pacific Biosciences, Lowers Price Target to $10
Benzinga Newsdesk
-
Mar 22, 2024, 6:26AM
Tuesday, March 19, 2024
Top 5 Health Care Stocks Which Could Rescue Your Portfolio In March
Avi Kapoor
-
Mar 19, 2024, 8:08AM
Tuesday, March 12, 2024
How Is The Market Feeling About Pacific Biosciences?
Benzinga Insights
-
Mar 12, 2024, 3:30PM
Thursday, March 07, 2024
Top 3 Health Care Stocks That Could Lead To Your Biggest Gains In March
Avi Kapoor
-
Mar 7, 2024, 7:18AM
Monday, February 19, 2024
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
-
Feb 19, 2024, 12:30PM
Friday, February 16, 2024
Pacific Biosciences of California shares are trading lower. The company reported Q4 financial results.
Benzinga Newsdesk
-
Feb 16, 2024, 12:31PM
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
-
Feb 16, 2024, 12:31PM
Thursday, February 15, 2024
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
-
Feb 15, 2024, 4:31PM
Pacific Biosciences: Q4 Earnings Insights
Benzinga Insights
-
Feb 15, 2024, 4:10PM
Pacific Biosciences Q4 2023 Adj EPS $(0.27) Beats $(0.29) Estimate, Sales $58.36M Beat $57.49M Estimate
Benzinga Newsdesk
-
Feb 15, 2024, 4:08PM
Earnings Scheduled For February 15, 2024
Benzinga Insights
-
Feb 15, 2024, 5:17AM
Wednesday, February 14, 2024
Earnings Preview: Pacific Biosciences
Benzinga Insights
-
Feb 14, 2024, 12:02PM
Monday, February 12, 2024
Cathie Wood-led Ark Invest Dives Into Pinterest Stock Amid Q4 Turbulence: Purchases Over $23M Worth
Benzinga Neuro
-
Feb 12, 2024, 9:35PM
Friday, February 09, 2024
Cathie Wood Trims Nvidia, Shopify Stakes To Pump Whopping $40M Into Pinterest Despite Q4 Revenue Miss
Benzinga Neuro
-
Feb 8, 2024, 11:49PM
Wednesday, February 07, 2024
Cathie Wood's Ark Invest Sheds $2.8M Worth Of Nvidia Shares Amid AI Hype, Picks Up Robinhood Stock Worth $1.3M
Benzinga Neuro
-
Feb 7, 2024, 10:20PM
Tuesday, January 16, 2024
Cathie Wood's Ark Invest Liquidates $15.8M Worth Of ProShares Bitcoin Strategy ETF Units
Benzinga Neuro
-
Jan 16, 2024, 10:39PM
Monday, January 15, 2024
PacBio Announces New Nanobind PanDNA Kit Enabling HiFi Optimized DNA Extraction Solutions
Benzinga Newsdesk
-
Jan 15, 2024, 6:28PM
Thursday, January 11, 2024
What's Going On With Pacific Biosciences Stock?
Erica Kollmann
-
Jan 11, 2024, 2:32PM
Aspen Aerogels Issues Business Update, Joins Plug Power, SunPower And Other Big Stocks Moving Lower On Thursday
Avi Kapoor
-
Jan 11, 2024, 10:32AM
Monday, January 08, 2024
PacBio shares are trading lower after the company announced preliminary Q4 and FY23 revenue results.
Benzinga Newsdesk
-
Jan 8, 2024, 2:34PM
Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Avi Kapoor
-
Jan 8, 2024, 1:36PM
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
-
Jan 8, 2024, 12:30PM
Boeing, Pacific Biosciences of California And Other Big Stocks Moving Lower On Monday
Avi Kapoor
-
Jan 8, 2024, 11:46AM
Pacific Biosciences Of California Announced Earlier Sees Prelim. FY23 Revenue $200.5M Vs $197.97M Est.
Benzinga Newsdesk
-
Jan 8, 2024, 10:04AM
Pacific Biosciences Of California Announced Earlier Sees Prelim. Q4 Revenue ~$58.4M Vs $55.82M Est.
Benzinga Newsdesk
-
Jan 8, 2024, 10:02AM
Tuesday, December 19, 2023
What's Up With Pacific Biosciences Stock?
Ryan Gustafson
-
Dec 19, 2023, 5:52PM
Thursday, December 14, 2023
Why Is Pacific Biosciences of California Stock Soaring Today?
Vandana Singh
-
Dec 14, 2023, 3:41PM
Why Amtech Systems Shares Are Trading Higher By Over 30%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Avi Kapoor
-
Dec 14, 2023, 12:56PM
Pacific Biosciences of California shares are trading higher after Stephens & Co initiated coverage on the stock with an Overweight rating and $11 price target.
Benzinga Newsdesk
-
Dec 14, 2023, 11:31AM
Jabil Posts Upbeat Earnings, Joins Moderna, Rivian Automotive And Other Big Stocks Moving Higher On Thursday
Avi Kapoor
-
Dec 14, 2023, 10:15AM
Guggenheim Initiates Coverage On Pacific Biosciences with Neutral Rating
Benzinga Newsdesk
-
Dec 14, 2023, 6:26AM
Stephens & Co. Initiates Coverage On Pacific Biosciences with Overweight Rating, Announces Price Target of $11
Benzinga Newsdesk
-
Dec 14, 2023, 5:53AM
Wednesday, December 13, 2023
Analyst Expectations for Pacific Biosciences's Future
Benzinga Insights
-
Dec 13, 2023, 10:00AM
Wolfe Research Initiates Coverage On Pacific Biosciences with Peer Perform Rating
Benzinga Newsdesk
-
Dec 13, 2023, 5:23AM
Friday, November 17, 2023
Pacific Biosciences shares are trading higher after UBS upgraded the stock from Neutral to Buy but cut its price target from $13 to $10.
Benzinga Newsdesk
-
Nov 17, 2023, 12:18PM
UBS Upgrades Pacific Biosciences to Buy, Lowers Price Target to $10
Benzinga Newsdesk
-
Nov 17, 2023, 7:19AM
Tuesday, November 14, 2023
Why Beyond Air Shares Are Trading Lower By Around 37%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Lisa Levin
-
Nov 14, 2023, 2:05PM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch